UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- EBITDA, 2025
- $1.6B
- YoY, 2025
- +8.9%
- 5-year CAGR
- +19.7%
- 10-year CAGR
- +8.0%
EBITDA
EBITDA by fiscal year
| Period | EBITDA | YoY |
|---|---|---|
| 2025 | $1.6B | +8.9% |
| 2024 | $1.4B | +17.1% |
| 2023 | $1.2B | +20.1% |
| 2022 | $1.0B | +70.2% |
| 2021 | $606M | −5.9% |
| 2020 | $644M | — |
| 2019 | −$142M | — |
| 2018 | $841M | −0.5% |
| 2017 | $846M | −22.6% |
| 2016 | $1.1B | +49.4% |
| 2015 | $732M | +28.2% |
| 2014 | $571M | +76.4% |
| 2013 | $324M | −27.9% |
| 2012 | $449M | +32.7% |
| 2011 | $338M | +78.8% |
| 2010 | $189M | +409.4% |
| 2009 | $37M | — |
| 2008 | −$78M | — |